Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Herpes Simplex Virus Type 2 (HSV-2) IgG antibody testing is a serological assay used to detect past or latent infection with HSV-2, the primary cause of genital herpes. IgG antibodies typically develop within weeks after initial infection and persist lifelong, indicating prior exposure. A positive HSV-2 IgG result confirms previous infection but does not indicate active viral shedding or symptom presence. This test is valuable in asymptomatic individuals, those with recurrent genital lesions, and in screening sexual partners. It is not useful for diagnosing acute infection, for which direct detection by PCR or viral culture from lesions is preferred. Negative results generally indicate no prior HSV-2 exposure, although testing too soon after exposure may result in false negatives due to the window period.
References
Ashley-Morrow, R., Krantz, E., & Wald, A. (2003). Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sexually Transmitted Diseases, 30(4), 310–314. https://doi.org/10.1097/00007435-200304000-00011
Centers for Disease Control and Prevention (CDC). (2021). Genital herpes—CDC fact sheet. Retrieved from https://www.cdc.gov/std/herpes/stdfact-herpes.htm
Wald, A., & Link, K. (2002). Risk of human immunodeficiency virus infection in herpes simplex virus type 2 seropositive persons: A meta-analysis. The Journal of Infectious Diseases, 185(1), 45–52. https://doi.org/10.1086/338416
Statement on Medical Necessity
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Solaris requires ICD-10 codes with each order for lab testing and both the tests ordered and the diagnosis should be documented in the provider’s medical record for the patient. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.
Panels and Profiles
Solaris offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Solaris encourages clients to contact their Solaris representative if the testing configurations shown do not meet individual needs for any reason, or if some other combination of procedures is needed.
CPT Codes
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Solaris may bill specific carriers using codes other than what is shown.
For questions or inquiries related to testing please reach out to
customerservice@solarisdx.com or contact us by phone at (844) 550-0308.
Contact Information
Helpful Links
